Cargando…
In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models
NZ2114 is a promising candidate for therapeutic application owing to potent activity to gram-positive bacterium such as Streptococcus pneumoniae and Staphylococcus aureus. This work is the first report to describe the in vitro and in vivo antibacterial characteristics of NZ2114 against Streptococcus...
Autores principales: | Jiao, Jian, Mao, Ruoyu, Teng, Da, Wang, Xiumin, Hao, Ya, Yang, Na, Wang, Xiao, Feng, Xingjun, Wang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318318/ https://www.ncbi.nlm.nih.gov/pubmed/28220445 http://dx.doi.org/10.1186/s13568-017-0347-8 |
Ejemplares similares
-
Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo
por: Wang, Xiao, et al.
Publicado: (2018) -
Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus
por: Chen, Huixian, et al.
Publicado: (2017) -
Effect of NZ2114 against Streptococcus dysgalactiae biofilms and its application in murine mastitis model
por: Yang, Na, et al.
Publicado: (2022) -
Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
por: Mao, Ruoyu, et al.
Publicado: (2015) -
Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis
por: Yang, Na, et al.
Publicado: (2017)